CHADDS FORD, Pa., May 31, 2011 /PRNewswire/ — Endo
Pharmaceuticals (Nasdaq:
ENDP) today announced that Julie McHugh, chief operating
officer and Alan Levin, executive vice president and chief
financial officer will present a corporate overview at the
Jefferies Global Healthcare Conference on Tuesday, June 7, 2011 at
9:00 a.m. ET. The conference will be held at the Grand Hyatt
in New York City, NY.
A live webcast and audio archive of the presentation will be
available on the company’s website at http://www.endo.com/. Click
on Investor Relations, and then the link to the Event and
Presentation. Participants should allow approximately ten
minutes prior to the presentation’s start time to visit the site
and download any streaming media software needed to listen to the
Internet webcast.
About Endo
Endo Pharmaceuticals is a U.S.-based, specialty healthcare
solutions company, focused on high-value branded products and
specialty generics. Endo is redefining its position in the
healthcare marketplace by anticipating and embracing the evolution
of health decisions based on the need for high-quality and
cost-effective care. We aim to be the premier partner to healthcare
professionals and payment providers, delivering an innovative suite
of complementary diagnostics, drugs, devices and clinical data to
meet the needs of patients in areas such as pain, urology, oncology
and endocrinology. For more information about Endo Pharmaceuticals,
and its wholly owned subsidiaries HealthTronics, Inc. and Qualitest
Pharmaceuticals, please visit http://www.endo.com/.
‘/>”/>
